Edition:
United States

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

0.99USD
24 May 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.99
Open
$1.00
Day's High
$1.00
Day's Low
$0.96
Volume
9,583
Avg. Vol
90,090
52-wk High
$2.65
52-wk Low
$0.69

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 0.00 -0.250
Sep 0.00 -0.531
Jun 0.00 -0.278
FY 2017 Mar '17 0.00 -0.325
Dec 1.25 -0.343
Sep 0.00 -0.416
Jun 0.00 -0.514
FY 2016 Mar '16 0.00 -4.445
Dec 0.00 -1.952
Sep 0.00 -5.263
Jun 0.00 -19.233
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-18 1 0.00 0.00 0.00 0.00
Year Ending Mar-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.55 -0.55 -0.55 -0.39
Year Ending Mar-18 1 -2.08 -2.08 -2.08 -1.72
Year Ending Mar-19 1 -1.89 -1.89 -1.89 -0.90
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.26 32.60
P/E High - Last 5 Yrs. -- 41.40 47.30
P/E Low - Last 5 Yrs. -- 23.40 24.74
Beta -0.70 0.80 0.79
Price to Sales (TTM) -- 3.39 8.19
Price to Book (MRQ) 2.17 3.53 4.29
Price to Tangible Book (MRQ) 2.20 4.40 5.81
Price to Cash Flow (TTM) -- 19.28 21.74
% Owned Institutions 13.56 1.30 2.45

Dividends

  Company industry sector
Dividend Yield -- 1.80 1.67
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.63 4.06
Payout Ratio(TTM) -- 16.85 17.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 3.97 5.07
Sales (TTM) vs TTM 1 Yr. Ago -100.00 10.70 13.02
Sales - 5 Yr. Growth Rate -1.41 7.39 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago 27.29 39.60 35.88
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 7.06 8.59
Capital Spending - 5 Yr. Growth Rate 49.14 8.05 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.55 2.53
Current Ratio (MRQ) 10.53 3.62 3.60
LT Debt to Equity (MRQ) 0.10 10.62 12.99
Total Debt to Equity (MRQ) 0.55 13.16 16.09
Interest Coverage (TTM) -3,447.08 40.51 35.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.42 55.04
Gross Margin - 5 Yr. Avg. -- 52.71 52.82
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -3,202.01 18.50 15.90
Operating Margin (TTM) -- 14.61 0.15
Operating Margin - 5 Yr. Avg. -5,471.17 14.23 11.15
Pre-Tax Margin (TTM) -- 14.89 2.24
Pre-Tax Margin - 5 Yr. Avg. -6,012.32 14.51 11.36
Net Profit Margin (TTM) -- 11.30 -1.19
Net Profit Margin - 5 Yr. Avg. -6,013.25 10.80 7.65
Effective Tax Rate (TTM) -- 22.49 31.40
Effective Tax Rate - 5 Yr. Avg. -- 23.91 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 834,642,710 724,115,471
Net Income/Employee (TTM) -- 97,014,216 84,106,404
Receivable Turnover (TTM) -- 5.60 5.75
Inventory Turnover (TTM) -- 2.52 3.59
Asset Turnover (TTM) 0.00 0.88 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -127.40 10.56 10.07
Return on Assets - 5 Yr. Avg. -1,968.05 11.65 11.08
Return on Investment (TTM) -151.49 13.20 12.74
Return on Investment - 5 Yr. Avg. -- 15.07 14.36
Return on Equity (TTM) -218.33 14.98 14.66
Return on Equity - 5 Yr. Avg. -- 16.32 15.72
  1 Year 3 Year 5 Year
Sales % -- -- -1.41
EPS (TTM) % 94.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for VistaGen Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.56%
# of Holders: 20
Total Shares Held: 3,105,475
3 Mo. Net Change: -2,548,905
# New Positions: 8
# Closed Positions: 6
# Increased Positions: 10
# Reduced Positions: 8
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.